Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Pharma & Healthcare

>>

Global Oral Hypoglyceimic Agents OHAs Market


Global Oral Hypoglyceimic Agents (OHAs) Market By Product, Applications, Players - Market Trends and Forecasts to 2025

Report code: SDMRPH654313 | Industry: Pharma & Healthcare | Published On: 5/17/2019


Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.
At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market.

The global Oral Hypoglyceimic Agents (OHAs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oral Hypoglyceimic Agents (OHAs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Hypoglyceimic Agents (OHAs) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oral Hypoglyceimic Agents (OHAs) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oral Hypoglyceimic Agents (OHAs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novonordisk
Sanofi-Aventis
Servier
Huadong Medicine
Wanbang Biopharmaceuticals
Double-Crane Pharmaceutical
Guangzhou Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Sulfonylureas
Metformin
Thiazolidinediones
Alpha-Glucosidase Inhibitors

Segment by Application
Hospitals and Clinics
Others

Table  of  Contents

Report  Introduction
1  Industry  Overview  of  Oral  Hypoglyceimic  Agents  (OHAs)
        1.1  Definition  of  Oral  Hypoglyceimic  Agents  (OHAs)
        1.2  Oral  Hypoglyceimic  Agents  (OHAs)  Segment  by  Type
                1.2.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Growth  Rate  Comparison  by  Types  (2014-2025)
                1.2.2  Sulfonylureas
                1.2.3  Metformin
                1.2.4  Thiazolidinediones
                1.2.5  Alpha-Glucosidase  Inhibitors
        1.3  Oral  Hypoglyceimic  Agents  (OHAs)  Segment  by  Applications
                1.3.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Consumption  Comparison  by  Applications  (2014-2025)
                1.3.2  Hospitals  and  Clinics
                1.3.3  Others
        1.4  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Overall  Market
                1.4.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue  (2014-2025)
                1.4.2  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Production  (2014-2025)
                1.4.3  North  America  Oral  Hypoglyceimic  Agents  (OHAs)  Status  and  Prospect  (2014-2025)
                1.4.4  Europe  Oral  Hypoglyceimic  Agents  (OHAs)  Status  and  Prospect  (2014-2025)
                1.4.5  China  Oral  Hypoglyceimic  Agents  (OHAs)  Status  and  Prospect  (2014-2025)
                1.4.6  Japan  Oral  Hypoglyceimic  Agents  (OHAs)  Status  and  Prospect  (2014-2025)
                1.4.7  Southeast  Asia  Oral  Hypoglyceimic  Agents  (OHAs)  Status  and  Prospect  (2014-2025)
                1.4.8  India  Oral  Hypoglyceimic  Agents  (OHAs)  Status  and  Prospect  (2014-2025)

2  Manufacturing  Cost  Structure  Analysis
        2.1  Raw  Material  and  Suppliers
        2.2  Manufacturing  Cost  Structure  Analysis  of  Oral  Hypoglyceimic  Agents  (OHAs)
        2.3  Manufacturing  Process  Analysis  of  Oral  Hypoglyceimic  Agents  (OHAs)
        2.4  Industry  Chain  Structure  of  Oral  Hypoglyceimic  Agents  (OHAs)

3  Development  and  Manufacturing  Plants  Analysis  of  Oral  Hypoglyceimic  Agents  (OHAs)
        3.1  Capacity  and  Commercial  Production  Date
        3.2  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Manufacturing  Plants  Distribution
        3.3  Major  Manufacturers  Technology  Source  and  Market  Position  of  Oral  Hypoglyceimic  Agents  (OHAs)
        3.4  Recent  Company  Developments  and  Expansion  Plans

4  Key  Figures  of  Major  Manufacturers
        4.1  Oral  Hypoglyceimic  Agents  (OHAs)  Production  and  Capacity  Analysis
        4.2  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue  Analysis
        4.3  Oral  Hypoglyceimic  Agents  (OHAs)  Price  Analysis
        4.4  Market  Concentration  Degree

5  Oral  Hypoglyceimic  Agents  (OHAs)  Regional  Market  Analysis
        5.1  Oral  Hypoglyceimic  Agents  (OHAs)  Production  by  Regions
                5.1.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Production  by  Regions
                5.1.2  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue  by  Regions
        5.2  Oral  Hypoglyceimic  Agents  (OHAs)  Consumption  by  Regions
        5.3  North  America  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Analysis
                5.3.1  North  America  Oral  Hypoglyceimic  Agents  (OHAs)  Production
                5.3.2  North  America  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue
                5.3.3  Key  Manufacturers  in  North  America
                5.3.4  North  America  Oral  Hypoglyceimic  Agents  (OHAs)  Import  and  Export
        5.4  Europe  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Analysis
                5.4.1  Europe  Oral  Hypoglyceimic  Agents  (OHAs)  Production
                5.4.2  Europe  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue
                5.4.3  Key  Manufacturers  in  Europe
                5.4.4  Europe  Oral  Hypoglyceimic  Agents  (OHAs)  Import  and  Export
        5.5  China  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Analysis
                5.5.1  China  Oral  Hypoglyceimic  Agents  (OHAs)  Production
                5.5.2  China  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue
                5.5.3  Key  Manufacturers  in  China
                5.5.4  China  Oral  Hypoglyceimic  Agents  (OHAs)  Import  and  Export
        5.6  Japan  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Analysis
                5.6.1  Japan  Oral  Hypoglyceimic  Agents  (OHAs)  Production
                5.6.2  Japan  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue
                5.6.3  Key  Manufacturers  in  Japan
                5.6.4  Japan  Oral  Hypoglyceimic  Agents  (OHAs)  Import  and  Export
        5.7  Southeast  Asia  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Analysis
                5.7.1  Southeast  Asia  Oral  Hypoglyceimic  Agents  (OHAs)  Production
                5.7.2  Southeast  Asia  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue
                5.7.3  Key  Manufacturers  in  Southeast  Asia
                5.7.4  Southeast  Asia  Oral  Hypoglyceimic  Agents  (OHAs)  Import  and  Export
        5.8  India  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Analysis
                5.8.1  India  Oral  Hypoglyceimic  Agents  (OHAs)  Production
                5.8.2  India  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue
                5.8.3  Key  Manufacturers  in  India
                5.8.4  India  Oral  Hypoglyceimic  Agents  (OHAs)  Import  and  Export

6  Oral  Hypoglyceimic  Agents  (OHAs)  Segment  Market  Analysis  (by  Type)
        6.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Production  by  Type
        6.2  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Revenue  by  Type
        6.3  Oral  Hypoglyceimic  Agents  (OHAs)  Price  by  Type

7  Oral  Hypoglyceimic  Agents  (OHAs)  Segment  Market  Analysis  (by  Application)
        7.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Consumption  by  Application
        7.2  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Consumption  Market  Share  by  Application  (2014-2019)

8  Oral  Hypoglyceimic  Agents  (OHAs)  Major  Manufacturers  Analysis
        8.1  Pfizer
                8.1.1  Pfizer  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.1.2  Pfizer  Report  Overview,  Application  and  Specification
                8.1.3  Pfizer  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.1.4  Main  Business  and  Markets  Served
        8.2  GlaxoSmithKline
                8.2.1  GlaxoSmithKline  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.2.2  GlaxoSmithKline  Report  Overview,  Application  and  Specification
                8.2.3  GlaxoSmithKline  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.2.4  Main  Business  and  Markets  Served
        8.3  Bayer
                8.3.1  Bayer  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.3.2  Bayer  Report  Overview,  Application  and  Specification
                8.3.3  Bayer  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.3.4  Main  Business  and  Markets  Served
        8.4  Bristol-Myers  Squibb
                8.4.1  Bristol-Myers  Squibb  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.4.2  Bristol-Myers  Squibb  Report  Overview,  Application  and  Specification
                8.4.3  Bristol-Myers  Squibb  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.4.4  Main  Business  and  Markets  Served
        8.5  Novonordisk
                8.5.1  Novonordisk  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.5.2  Novonordisk  Report  Overview,  Application  and  Specification
                8.5.3  Novonordisk  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.5.4  Main  Business  and  Markets  Served
        8.6  Sanofi-Aventis
                8.6.1  Sanofi-Aventis  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.6.2  Sanofi-Aventis  Report  Overview,  Application  and  Specification
                8.6.3  Sanofi-Aventis  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.6.4  Main  Business  and  Markets  Served
        8.7  Servier
                8.7.1  Servier  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.7.2  Servier  Report  Overview,  Application  and  Specification
                8.7.3  Servier  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.7.4  Main  Business  and  Markets  Served
        8.8  Huadong  Medicine
                8.8.1  Huadong  Medicine  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.8.2  Huadong  Medicine  Report  Overview,  Application  and  Specification
                8.8.3  Huadong  Medicine  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.8.4  Main  Business  and  Markets  Served
        8.9  Wanbang  Biopharmaceuticals
                8.9.1  Wanbang  Biopharmaceuticals  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.9.2  Wanbang  Biopharmaceuticals  Report  Overview,  Application  and  Specification
                8.9.3  Wanbang  Biopharmaceuticals  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.9.4  Main  Business  and  Markets  Served
        8.10  Double-Crane  Pharmaceutical
                8.10.1  Double-Crane  Pharmaceutical  Oral  Hypoglyceimic  Agents  (OHAs)  Production  Sites  and  Area  Served
                8.10.2  Double-Crane  Pharmaceutical  Report  Overview,  Application  and  Specification
                8.10.3  Double-Crane  Pharmaceutical  Oral  Hypoglyceimic  Agents  (OHAs)  Production,  Revenue,  Ex-factory  Price  and  Gross  Margin  (2014-2019)
                8.10.4  Main  Business  and  Markets  Served
        8.11  Guangzhou  Pharmaceutical

9  Development  Trend  of  Analysis  of  Oral  Hypoglyceimic  Agents  (OHAs)  Market
        9.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Trend  Analysis
                9.1.1  Global  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Size  (Volume  and  Value)  Forecast  2019-2025
        9.2  Oral  Hypoglyceimic  Agents  (OHAs)  Regional  Market  Trend
                9.2.1  North  America  Oral  Hypoglyceimic  Agents  (OHAs)  Forecast  2019-2025
                9.2.2  Europe  Oral  Hypoglyceimic  Agents  (OHAs)  Forecast  2019-2025
                9.2.3  China  Oral  Hypoglyceimic  Agents  (OHAs)  Forecast  2019-2025
                9.2.4  Japan  Oral  Hypoglyceimic  Agents  (OHAs)  Forecast  2019-2025
                9.2.5  Southeast  Asia  Oral  Hypoglyceimic  Agents  (OHAs)  Forecast  2019-2025
                9.2.6  India  Oral  Hypoglyceimic  Agents  (OHAs)  Forecast  2019-2025
        9.3  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Trend  (Product  Type)
        9.4  Oral  Hypoglyceimic  Agents  (OHAs)  Market  Trend  (Application)

10.1  Marketing  Channel
        10.1.1  Direct  Marketing
        10.1.2  Indirect  Marketing
        10.3  Oral  Hypoglyceimic  Agents  (OHAs)  Customers

11  Market  Dynamics
        11.1  Market  Trends
        11.2  Opportunities
        11.3  Market  Drivers
        11.4  Challenges
        11.5  Influence  Factors

12  Conclusion
13  Appendix
        13.1  Methodology/Research  Approach
                13.1.1  Research  Programs/Design
                13.1.2  Market  Size  Estimation
                13.1.3  Market  Breakdown  and  Data  Triangulation
        13.2  Data  Source
                13.2.1  Secondary  Sources
                13.2.2  Primary  Sources
        13.3  Author  List
        13.4  Disclaimer
We employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach

Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.

Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis

Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price

Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT